The ideal endoscopic methods for managing esophageal squamous cell dysplasia and
superficial neoplasia remain controversial. The use of endoscopic resection or endoscopic …

Esophageal cancer is highly lethal and causes more than 400,000 deaths per year
worldwide. 1 In the Asia-Pacific region, esophageal squamous cell carcinoma is the major …

BACKGROUND: Radiofrequency ablation (RFA) is safe and effective for eradicating
neoplasia in Barrett's esophagus. OBJECTIVE: To evaluate RFA for eradicating early …

Background and study aims: Endoscopic radiofrequency ablation (RFA) is an established
therapy for Barrett's esophagus. Preliminary reports, limited by low patient numbers, also …

Radiofrequency ablation (RFA) represents an exciting advance for the treatment of Barrett's
esophagus. The research work on RFA performed to date has involved a stepwise …

Barrett's esophagus (BE) is a premalignant condition in which the normal squamous cell
lining of the esophagus is replaced by columnar epithelium containing specialized intestinal …

BACKGROUND: For selected patients with high-grade dysplasia (HGD) and/or early
esophageal squamous cell cancer (ESCC) of the esophagus, endoscopic therapy …

Although adenocarcinoma of the esophagus (EAC) and its associated precursor lesion,
Barrett's esophagus (BE), receive the bulk of attention in the United States and other …

Background Esophageal squamous cell carcinoma (ESCC) is the 6th most common cause
of cancer death worldwide (400,000/year). Moderate and high-grade intraepithelial …

Background Endoscopic radiofrequency ablation (RFA) is a treatment option for early
esophageal squamous cell neoplasia (ESCN); however, long-term follow-up studies are …